{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:54:54Z","timestamp":1791489294467,"version":"4.3.4"},"reference-count":28,"publisher":"Japanese Association for Laboratory Animal Science","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp. Anim."],"published-print":{"date-parts":[[2017]]},"DOI":"10.1538\/expanim.16-0097","type":"journal-article","created":{"date-parts":[[2017,3,2]],"date-time":"2017-03-02T22:08:07Z","timestamp":1488492487000},"page":"199-208","source":"Crossref","is-referenced-by-count":13,"title":["Difference of two new LCMV strains in lethality and viral genome load in tissues"],"prefix":"10.1538","volume":"66","author":[{"given":"Toshikazu","family":"Takagi","sequence":"first","affiliation":[{"name":"Division of Comparative Medicine, Center for Frontier Life Sciences, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki, Nagasaki 852-8523, Japan"},{"name":"Quality Control Department, Bio Technical Center, Japan SLC, Inc., 3-5-1 Aoihigashi, Naka, Hamamatsu, Shizuoka 433-8114, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Ohsawa","sequence":"additional","affiliation":[{"name":"Division of Comparative Medicine, Center for Frontier Life Sciences, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, Nagasaki 852-8523, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoki","family":"Yamanaka","sequence":"additional","affiliation":[{"name":"Division of Comparative Medicine, Center for Frontier Life Sciences, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, Nagasaki 852-8523, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Division of Radiation Biology and Protection, Center for Frontier Life Sciences, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, Nagasaki 852-8523, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Sato","sequence":"additional","affiliation":[{"name":"Division of Comparative Medicine, Center for Frontier Life Sciences, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, Nagasaki 852-8523, Japan"},{"name":"National Institute for Physiological Sciences, National Institutes of Natural Sciences, 38 Nishigonaka, Myodaiji, Okazaki, Aichi 444-8585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Ohsawa","sequence":"additional","affiliation":[{"name":"Division of Comparative Medicine, Center for Frontier Life Sciences, Nagasaki University, 1-12-4 Sakamoto, Nagasaki, Nagasaki 852-8523, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"439","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Armstrong C. and Lillie R.D. 1934. Experimental lymphocytic choriomeningitis of monkeys and mice produced by a virus encountered in studies of the 1933 St. Louis encephalitis epidemic. <i>Public Health Rep.<\/i> 49: 1019\u20131027.","DOI":"10.2307\/4581290"},{"key":"2","unstructured":"2. Barthold S.W. and Smith A.L. 2007. Lymphocytic choriomeningitis virus. pp. 179\u2013213. <i>In<\/i>: The Mouse in Biomedical Research, 2nd ed Vol. 2. (Fox, J.G., Barthold, S.W., Davisson, M.T., Newcomer, C.E., Quimby, F.W. and Smith, A.L., eds.), Academic Press, New York."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Barton L.L. 1996. Lymphocytic choriomeningitis virus: a neglected central nervous system pathogen. <i>Clin. Infect. Dis.<\/i> 22: 197.","DOI":"10.1093\/clinids\/22.1.197"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Barton L.L. and Hyndman N.J. 2000. Lymphocytic choriomeningitis virus: reemerging central nervous system pathogen. <i>Pediatrics<\/i> 105: E35.","DOI":"10.1542\/peds.105.3.e35"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Barton L.L., Peters C.J., and Ksiazek T.G. 1995. Lymphocytic choriomeningitis virus: an unrecognized teratogenic pathogen. <i>Emerg. Infect. Dis.<\/i> 1: 152\u2013153.","DOI":"10.3201\/eid0104.950410"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Beck J.A., Lloyd S., Hafezparast M., Lennon-Pierce M., Eppig J.T., Festing M.F., and Fisher E.M. 2000. Genealogies of mouse inbred strains. <i>Nat. Genet.<\/i> 24: 23\u201325.","DOI":"10.1038\/71641"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Blackburn S.D., Crawford A., Shin H., Polley A., Freeman G.J., and Wherry E.J. 2010. Tissue-specific differences in PD-1 and PD-L1 expression during chronic viral infection: implications for CD8 T-cell exhaustion. <i>J. Virol.<\/i> 84: 2078\u20132089.","DOI":"10.1128\/JVI.01579-09"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Botten J.W. and Kotturi M.F. 2007. Adaptive immunity to Lymphocyctic choriomeningitis virus: new insights into antigenic determinants. <i>Future Virol.<\/i> 2: 495\u2013508.","DOI":"10.2217\/17460794.2.5.495"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Gairin J.E., Mazarguil H., Hudrisier D., and Oldstone M.B. 1995. Optimal lymphocytic choriomeningitis virus sequences restricted by H-2Db major histocompatibility complex class I molecules and presented to cytotoxic T lymphocytes. <i>J. Virol.<\/i> 69: 2297\u20132305.","DOI":"10.1128\/JVI.69.4.2297-2305.1995"},{"key":"10","unstructured":"10. Ike F., Bourgade F., Ohsawa K., Sato H., Morikawa S., Saijo M., Kurane I., Takimoto K., Yamada Y.K., Jaubert J., Berard M., Nakata H., Hiraiwa N., Mekada K., Takakura A., Itoh T., Obata Y., Yoshiki A., and Montagutelli X. 2007. Lymphocytic choriomeningitis infection undetected by dirty-bedding sentinel monitoring and revealed after embryo transfer of an inbred strain derived from wild mice. <i>Comp. Med.<\/i> 57: 272\u2013281."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Jacoby R.O., Fox J.G., and Davisson M. 2002. Biology and diseases of mice, lymphocytic choriomeningitis virus (LCMV) infection. pp. 66\u201369. <i>In<\/i>: Laboratory Animal Medicine, 2nd ed. (Fox, J.G., Andersen, L.C., Loew, F.M., and Quimby, F.W., eds.), Academic Press, New York.","DOI":"10.1016\/B978-012263951-7\/50006-5"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Leist T., Althage A., Haenseler E., Hengartner H., and Zinkernagel R.M. 1989. Major histocompatibility complex-linked susceptibility or resistance to disease caused by a noncytopathic virus varies with the disease parameter evaluated. <i>J. Exp. Med.<\/i> 170: 269\u2013277.","DOI":"10.1084\/jem.170.1.269"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. McCausland M.M. and Crotty S. 2008. Quantitative PCR technique for detecting lymphocytic choriomeningitis virus in vivo. <i>J. Virol. Methods<\/i> 147: 167\u2013176.","DOI":"10.1016\/j.jviromet.2007.08.025"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Meritet J.F., Krivine A., Lewin F., Poissonnier M.H., Poizat R., Loget P., Rozenberg F., and Lebon P. 2009. A case of congenital lymphocytic choriomeningitis virus (LCMV) infection revealed by hydrops fetalis. <i>Prenat. Diagn.<\/i> 29: 626\u2013627.","DOI":"10.1002\/pd.2240"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Morita C., Matsuura Y., Fujii H., Joh K., Baba K., Kato M., and Hisada M. 1991. Isolation of lymphocytic choriomeningitis virus from wild house mice (Mus musculus) in Osaka Port, Japan. <i>J. Vet. Med. Sci.<\/i> 53: 889\u2013892.","DOI":"10.1292\/jvms.53.889"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Murali-Krishna K., Altman J.D., Suresh M., Sourdive D.J., Zajac A.J., Miller J.D., Slansky J., and Ahmed R. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. <i>Immunity<\/i> 8: 177\u2013187.","DOI":"10.1016\/S1074-7613(00)80470-7"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Palacios G., Druce J., Du L., Tran T., Birch C., Briese T., Conlan S., Quan P.L., Hui J., Marshall J., Simons J.F., Egholm M., Paddock C.D., Shieh W.J., Goldsmith C.S., Zaki S.R., Catton M., and Lipkin W.I. 2008. A new arenavirus in a cluster of fatal transplant-associated diseases. <i>N. Engl. J. Med.<\/i> 358: 991\u2013998.","DOI":"10.1056\/NEJMoa073785"},{"key":"18","unstructured":"18. Puissant C. and Houdebine L.M. 1990. An improvement of the single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. <i>Biotechniques<\/i> 8: 148\u2013149."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Reed L.J. and Muench H. 1938. A simple method of estimating fifty percent endpoints. <i>Am. J. Hyg.<\/i> 27: 493\u2013497.","DOI":"10.1093\/oxfordjournals.aje.a118408"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Rivers T.M. and McNair Scott T.F. 1935. Meningitis in man caused by a filterable virus. <i>Science<\/i> 81: 439\u2013440.","DOI":"10.1126\/science.81.2105.439-a"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Salvato M., Borrow P., Shimomaye E., and Oldstone M.B. 1991. Molecular basis of viral persistence: a single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-lymphocyte response and establishment of persistence. <i>J. Virol.<\/i> 65: 1863\u20131869.","DOI":"10.1128\/JVI.65.4.1863-1869.1991"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Sullivan B.M., Emonet S.F., Welch M.J., Lee A.M., Campbell K.P., de la Torre J.C., and Oldstone M.B. 2011. Point mutation in the glycoprotein of lymphocytic choriomeningitis virus is necessary for receptor binding, dendritic cell infection, and long-term persistence. <i>Proc. Natl. Acad. Sci. USA<\/i> 108: 2969\u20132974.","DOI":"10.1073\/pnas.1019304108"},{"key":"23","unstructured":"23. Takagi T., Ohsawa M., Morita C., Sato H., and Ohsawa K. 2012. Genomic analysis and pathogenic characteristics of lymphocytic choriomeningitis virus strains isolated in Japan. <i>Comp. Med.<\/i> 62: 185\u2013192."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Traub E. 1935. A filterable virus recovered from white mice. <i>Science<\/i> 81: 298\u2013299.","DOI":"10.1126\/science.81.2099.298"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Wilson E.B., Yamada D.H., Elsaesser H., Herskovitz J., Deng J., Cheng G., Aronow B.J., Karp C.L., and Brooks D.G. 2013. Blockade of chronic type I interferon signaling to control persistent LCMV infection. <i>Science<\/i> 340: 202\u2013207.","DOI":"10.1126\/science.1235208"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Wherry E.J., Blattman J.N., Murali-Krishna K., van der Most R., and Ahmed R. 2003. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. <i>J. Virol.<\/i> 77: 4911\u20134927.","DOI":"10.1128\/JVI.77.8.4911-4927.2003"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Zinkernagel R.M., Leist T., Hengartner H., and Althage A. 1985. Susceptibility to lymphocytic choriomeningitis virus isolates correlates directly with early and high cytotoxic T cell activity, as well as with footpad swelling reaction, and all three are regulated by H-2D. <i>J. Exp. Med.<\/i> 162: 2125\u20132141.","DOI":"10.1084\/jem.162.6.2125"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Zinkernagel R.M. and Doherty P.C. 1974. Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. <i>Nature<\/i> 248: 701\u2013702.","DOI":"10.1038\/248701a0"}],"container-title":["Experimental Animals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/expanim\/66\/3\/66_16-0097\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T03:20:52Z","timestamp":1658719252000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/expanim\/66\/3\/66_16-0097\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1538\/expanim.16-0097","relation":{},"ISSN":["1341-1357","1881-7122"],"issn-type":[{"value":"1341-1357","type":"print"},{"value":"1881-7122","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}